We are live on ! Find out more
DWTX

Dogwood Therapeutics
DWTX

9 hedge funds and large institutions have $4.55M invested in Dogwood Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.31% more ownership

Funds ownership: 0% → 0.31% (+0.31%)

Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MCM
Masters Capital Management
Georgia
+$4.32M
2
Jane Street
Jane Street
New York
+$918K
3
VF
Virtu Financial
New York
+$340K
4
Millennium Management
Millennium Management
New York
+$200K
5
UBS Group
UBS Group
Switzerland
+$32.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
1
Masters Capital Management
Georgia
$3.36M +$4.32M +17,918 New
Jane Street
2
Jane Street
New York
$715K +$918K +3,809 New
VF
3
Virtu Financial
New York
$264K +$340K +1,409 New
Millennium Management
4
Millennium Management
New York
$155K +$200K +828 New
UBS Group
5
UBS Group
Switzerland
$25K +$32.1K +133 New
Morgan Stanley
6
Morgan Stanley
New York
$11K +$14K +58 New
FIA
7
FNY Investment Advisers
New York
$7K +$9.64K +40 New
PFO
8
Pathstone Family Office
New Jersey
$4K +$4.82K +20 New
Osaic Holdings
9
Osaic Holdings
Arizona
$3K +$4.1K +17 New

DWTX Hedge Fund Activity: Q4 2020 in Review

9 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q4 2020, worth a combined $4.55M.

Buyers outnumbered sellers: 9 funds opened new DWTX positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Masters Capital Management, opening a new position worth an estimated $4.32M.

  • 9 institutional investors held Dogwood Therapeutics (DWTX) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $4.55M of Dogwood Therapeutics stock for Q4 2020.
  • 9 funds opened new Dogwood Therapeutics positions in Q4 2020 and 0 closed out, a net change of +9 holders.
  • The largest Dogwood Therapeutics buyer in Q4 2020 was Masters Capital Management, an estimated $4.32M added.

Based on aggregated 13F filings for Q4 2020.